Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) in Burkina Faso
Burkina Faso: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) was 66.0% in 2025. ▲ Rising
Latest (2025)
66.0%
Change on year
unchanged
World rank
7th
of 26 countries
All-time high
71.0%
in 2019
All-time low
0.0%
in 2016
Years of data
10
2016–2025
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) in Burkina Faso, 2016–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for meningococcal a conjugate (menga) vaccine immunization coverage (%) in Burkina Faso is 66.0%, measured in 2025.
The figure is down 7.0% over five years.
Over the whole period, meningococcal a conjugate (menga) vaccine immunization coverage (%) in Burkina Faso peaked at 71.0% in 2019 and was at its lowest, 0.0%, in 2016.
Burkina Faso ranks 7th of 26 countries on this measure, in the top quarter.
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) in Burkina Faso, year by year
| Year | Value | Change |
|---|---|---|
| 2016 | 0.0% | — |
| 2017 | 68.0% | — |
| 2018 | 70.0% | +2.9% |
| 2019 | 71.0% | +1.4% |
| 2020 | 71.0% | +0.0% |
| 2021 | 71.0% | +0.0% |
| 2022 | 68.0% | -4.2% |
| 2023 | 66.0% | -2.9% |
| 2024 | 66.0% | +0.0% |
| 2025 | 66.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 52.2% | 0.0% | 71.0% | 4 |
| 2020s | 68.0% | 66.0% | 71.0% | 6 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Population ages 30-34, female, annual growth rate 2.67 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0329 units per person (2025)
- Population ages 30-34, male, annual growth rate 2.75 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0326 units per person (2025)
Frequently asked questions
- What is meningococcal a conjugate (menga) vaccine immunization coverage (%) in Burkina Faso?
- Meningococcal a conjugate (menga) vaccine immunization coverage (%) in Burkina Faso was 66.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest meningococcal a conjugate (menga) vaccine immunization coverage (%) recorded in Burkina Faso?
- The highest recorded value was 71.0% in 2019.
- What is the lowest meningococcal a conjugate (menga) vaccine immunization coverage (%) recorded in Burkina Faso?
- The lowest recorded value was 0.0% in 2016.
- How does Burkina Faso rank for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Burkina Faso ranks 7th out of 26 countries with data for 2025.
- Where does this Burkina Faso data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).